Drugs / Dendritic and Cytokine-induced Killer Cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01821482 | May 2013 → May 2018 | hepatocellular carcinoma | Guangxi Medical University | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dendritic and Cytokine-induced Killer Cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01821482 ↗ |